Kämpfer H, Kolb N, Manderscheid M, Wetzler C, Pfeilschifter J, Frank S
Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany.
Mol Med. 2001 Jul;7(7):488-98.
Expression and enzymatic activity of heme oxygenase (HO) has been implicated in the development, as well as in the resolution, of inflammatory conditions. Because inflammation is central to tissue repair, we investigated the presence and potential functions of HO in an excisional model of normal and diabetes-impaired wound repair in mice.
Expression of HO-1 during cutaneous healing was analyzed by RNase protection assay, Western blot, and immunohistochemical techniques in a murine model of excisional repair. Furthermore, we determined HO-1-dependent release of proinflammatory cytokines from RAW 264.7 macrophages by enzyme-linked immunosorbent assay (ELISA).
Upon injury, we observed a rapid and strong increase in HO-1 mRNA and protein levels at the wound site. By contrast to normal repair, late stages of diabetes-impaired repair were associated with elevated HO-1 expression. Besides a few keratinocytes of the hyperproliferative epithelium, immunohistochemistry revealed infiltrating macrophages as the predominant and major source of HO-1 at the wound site. In vitro studies demonstrated the potency of exogenous and also endogenous nitric oxide (NO) to strongly induce HO-1 expression in RAW 264.7 macrophages. However, L-NIL-mediated enzymatic inhibition of inducible NO-synthase (iNOS) at the wound site in vivo was not paralleled by decreased HO-1 levels. In vitro inhibition of HO-1 enzymatic activity by tin protoporphyrin IX (SnPPIX) in RAW 264.7 macrophages markedly attenuated tumor necrosis factor-alpha (TNF-alpha), but strongly increased interleukin-1beta (IL-1beta) release in RAW 264.7 macrophages in vitro.
The observed injury-mediated increase in HO-1 mRNA and protein at the wound site was due to infiltrating HO-1 expressing monocytic cells. Macrophage-derived HO-1 expression was not under regulatory control by NO in skin repair. We provide evidence that HO-1 might exert a regulatory role in macrophage-derived cytokine release.
血红素加氧酶(HO)的表达及酶活性与炎症状态的发生发展及消退均有关联。由于炎症是组织修复的核心环节,我们在小鼠正常及糖尿病影响的伤口切除修复模型中研究了HO的存在情况及其潜在功能。
在切除修复的小鼠模型中,通过核糖核酸酶保护试验、蛋白质免疫印迹法及免疫组织化学技术分析了皮肤愈合过程中HO-1的表达。此外,我们通过酶联免疫吸附测定法(ELISA)测定了RAW 264.7巨噬细胞中HO-1依赖性促炎细胞因子的释放情况。
受伤后,我们观察到伤口部位HO-1 mRNA和蛋白水平迅速且显著升高。与正常修复不同,糖尿病影响修复的后期阶段与HO-1表达升高有关。免疫组织化学显示,除了增殖过度的上皮中的少数角质形成细胞外,浸润的巨噬细胞是伤口部位HO-1的主要来源。体外研究表明,外源性及内源性一氧化氮(NO)均能强烈诱导RAW 264.7巨噬细胞中HO-1的表达。然而,体内伤口部位L-NIL介导的诱导型一氧化氮合酶(iNOS)的酶活性抑制并未伴随HO-1水平的降低。原卟啉锡IX(SnPPIX)在体外对RAW 264.7巨噬细胞中HO-1酶活性的抑制显著减弱了肿瘤坏死因子-α(TNF-α)的释放,但却强烈增加了RAW 264.7巨噬细胞中白细胞介素-1β(IL-1β)的释放。
观察到的伤口部位HO-1 mRNA和蛋白因损伤而增加是由于表达HO-1的单核细胞浸润所致。在皮肤修复中,巨噬细胞来源的HO-1表达不受NO的调节控制。我们提供的证据表明,HO-1可能在巨噬细胞来源的细胞因子释放中发挥调节作用。